|
gptkbp:instanceOf
|
gptkb:company
|
|
gptkbp:acquiredBy
|
gptkb:Cytyc_Corporation
gptkb:Gen-Probe
|
|
gptkbp:CEO
|
gptkb:Stephen_P._MacMillan
|
|
gptkbp:country
|
gptkb:United_States
|
|
gptkbp:focusArea
|
breast health
gynecological health
skeletal health
diagnostic solutions
|
|
gptkbp:founded
|
1985
|
|
gptkbp:foundedBy
|
gptkb:David_Ellenbogen
gptkb:Jay_A._Stein
|
|
gptkbp:headquartersLocation
|
gptkb:Marlborough,_Massachusetts,_United_States
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Hologic, Inc.
|
|
gptkbp:industry
|
medical device
|
|
gptkbp:ISIN
|
US4364401012
|
|
gptkbp:netIncome
|
$1.13 billion (2023)
|
|
gptkbp:numberOfEmployees
|
~6,500
|
|
gptkbp:products
|
Mammography systems
Bone densitometry systems
Molecular diagnostic tests
Surgical devices
|
|
gptkbp:publiclyTraded
|
gptkb:NASDAQ
|
|
gptkbp:revenue
|
$5.07 billion (2023)
|
|
gptkbp:specializesIn
|
women's health
diagnostic products
surgical products
medical imaging systems
|
|
gptkbp:stockSymbol
|
gptkb:HOLX
|
|
gptkbp:website
|
https://www.hologic.com/
|
|
gptkbp:bfsParent
|
gptkb:Aptima_assays
gptkb:HOLX
gptkb:ThinPrep_Pap_Test
|
|
gptkbp:bfsLayer
|
7
|